A Transparency Market Research report forecasts that the worldwide market for drug-device combination products such as drug-eluting stents, bone grafts and infusion pumps will increase from $66 billion in 2012 to $115.1 billion by 2019. Growth will be driven in part by the rising number of chronic obstructive pulmonary disease, asthma and cardiovascular disease cases, the report notes.
Report: Drug-device combo market is poised for robust growth
SmartBrief Job Listings for Health Care
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
|Director of Clinical Research||
Regenesis Biomedical, Inc.
Meridian Health Plan
|Assistant Vice President - Dental Director||